Clinical Trials Logo

Filter by:
NCT ID: NCT00261781 Terminated - Clinical trials for Idiopathic Parkinson's Disease

Walking Capacity in Parkinson's Disease (PD-Walk)

Start date: May 2005
Phase: N/A
Study type: Interventional

The major aim of this study is to determine the efficacy of a home-based treadmill walking program in improving walking capacity and quality of life in people with early mid-stage Parkinson's disease(PD).

NCT ID: NCT00260858 Completed - Healthy Clinical Trials

GI Interlab 2 Study: Measuring the Glycaemic Index (GI) of Foods

Start date: November 2005
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the extent of and sources of variation in the glycaemic index values of foods measured by different laboratories around the world.

NCT ID: NCT00260832 Completed - Clinical trials for Acute Myeloid Leukemia

Trial of Decitabine in Patients With Acute Myeloid Leukemia

Start date: November 2005
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare the results in older patients who have newly diagnosed or secondary acute myeloid leukemia (AML) and who are to either receive decitabine or patient's choice with the physician's advice of either cytarabine or supportive care medication.

NCT ID: NCT00259922 Completed - Constipation Clinical Trials

Alvimopan For The Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain

Start date: August 2005
Phase: Phase 3
Study type: Interventional

Adults who are taking opioid therapy for persistent non-cancer pain and have resulting opioid-induced bowel dysfunction (OBD) will be randomized (1:1:1) to one of 2 alvimopan arms, or to placebo. The primary objective of this phase 3 confirmatory study is to compare alvimopan with placebo for efficacy in the treatment of OBD. The primary efficacy endpoint is based on frequency of bowel movements. Subjects will be required to: (1) track their bowel movements and other bowel symptoms and (2) attend 6 clinic visits over 4 months.

NCT ID: NCT00259376 Completed - Atrial Fibrillation Clinical Trials

American-Australian-African Trial With Dronedarone in Patients With Atrial Fibrillation or Atrial Flutter for the Maintenance of Sinus Rhythm

ADONIS
Start date: November 2001
Phase: Phase 3
Study type: Interventional

To assess the efficacy of dronedarone versus placebo for the maintenance of normal sinus rhythm after electrical, pharmacological or spontaneous conversion of atrial fibrillation/atrial flutter (AF/AFL). To assess the efficacy of dronedarone versus placebo on ventricular rate control in case of AF/AFL recurrence. To assess the efficacy of dronedarone versus placebo on AF/AFL-related symptoms.

NCT ID: NCT00259064 Completed - NSCLC Clinical Trials

Iressa v BSC (Best Supportive Care) in First Line NSCLC

INSTEP
Start date: September 2004
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of the study is to determine if the addition of Iressa to Best Supportive Care treatment will increase the progression free survival of chemo-naïve, poor performance status patients, with stage IIIB or IV NSCLC.

NCT ID: NCT00259012 Completed - Clinical trials for Gastroesophageal Reflux

Study Evaluating Pantoprazole Sodium Enteric-Coated Spheroid Suspension In Infants With Presumed GERD

Start date: November 2005
Phase: Phase 3
Study type: Interventional

The purpose of this study is to characterize the pharmacokinetic (PK) and pharmacodynamic (PD) profiles to determine the safety and tolerability of single and multiple doses of pantoprazole in infants aged 1 through 11 months.

NCT ID: NCT00258765 Terminated - Prostate Cancer Clinical Trials

Adjuvant Docetaxel-Zoledronic Acid in High-risk Early Prostate Cancer Following Prostatectomy.

Start date: May 2006
Phase: Phase 2
Study type: Interventional

Radical prostatectomy is used to treat early prostate cancer in otherwise well men, but is followed by later cancer relapse in 1 in 4 cases. This study aims to see if post-operative adjuvant therapy with a combination of zoledronic acid and docetaxel might help reduce relapse in such cases. Patients will be randomized to receive the adjuvant combination therapy or no therapy. All patients will be monitored closely for signs of relapse and treated appropriately with conventional salvage therapy.

NCT ID: NCT00258557 Completed - HIV Clinical Trials

TMC114-C211: Trial of an Investigational Protease Inhibitor TMC114 With Ritonavir ("TMC114/r") in HIV-1 Infected Patients Who Have Never Been Treated With Antiretroviral Medications.

Start date: September 2005
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare the efficacy, safety and tolerability of TMC114/r versus Kaletra (a combination pill of lopinavir and ritonavir, ("lpv/rtv") in HIV-1 infected patients who have never been treated with anti-retroviral medications (referred to as "treatment-naïve" patients).

NCT ID: NCT00257972 Completed - Bipolar Disorder Clinical Trials

Study of Aripiprazole in Patients With Bipolar I Disorder

Start date: October 2004
Phase: Phase 3
Study type: Interventional

The purpose of this research study is to compare the efficacy of aripiprazole with placebo in combination with lithium or valproate monotherapy, in the treatment of bipolar I patients with manic or mixed episodes.